Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7J1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,875
Award facts
- Contract value 100% obligated
- $25,875.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,875.36 to AmerisourceBergen Drug Corp for Cosentyx Unoready 300 mg pen 2mL, a specialty pharmaceutical product. The contract, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's IDC vehicle functions as a comprehensive global pharmaceutical support mechanism, enabling the supply of brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Cosentyx—an immunosuppressant medication—reflects the company's ongoing role in fulfilling specialized pharmaceutical needs within the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FV7J1?
SPE2DR26FV7J1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FV7J1 worth?
The government has obligated $25,875 on SPE2DR26FV7J1.
Is contract SPE2DR26FV7J1 an order under another contract?
Yes. SPE2DR26FV7J1 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7J1 competed?
The extent of competition for SPE2DR26FV7J1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award